Humira Market

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.

Humira Market contains market size and forecasts of Humira in global, including the following market information:

Global Humira Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Humira Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Humira companies in 2021 (%)

The global Humira market was valued at 17560 million in 2021 and is projected to reach US$ 9840.6 million by 2028, at a CAGR of -7.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Humira Syringe Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Humira include AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Humira manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Humira Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humira Market Segment Percentages, by Type, 2021 (%)

Humira Syringe

Humira Pen

Global Humira Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humira Market Segment Percentages, by Application, 2021 (%)

Ankylosing Spondylitis

Rheumatoid Arthritis

Crohn?s Disease

Others

Global Humira Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humira Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Humira revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Humira revenues share in global market, 2021 (%)

Key companies Humira sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Humira sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbbVie

Eisai

Cadila Healthcare

Torrent Pharmaceuticals

Amgen

Boehringer Ingelheim